Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
US8835434B2 · kind B2 · utility
2Cited by
25References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2009 |
| Grant date | Sep 16, 2014 |
| Priority date | — |
| Expiry date | Dec 26, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds, including pharmaceutically acceptable salts thereof, comprising the Formula (I): Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.